These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22706327)

  • 61. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation.
    Squeglia LM; Baker NL; McClure EA; Tomko RL; Adisetiyo V; Gray KM
    Addict Behav; 2016 Dec; 63():172-7. PubMed ID: 27521979
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial.
    Lintzeris N; Bhardwaj A; Mills L; Dunlop A; Copeland J; McGregor I; Bruno R; Gugusheff J; Phung N; Montebello M; Chan T; Kirby A; Hall M; Jefferies M; Luksza J; Shanahan M; Kevin R; Allsop D;
    JAMA Intern Med; 2019 Sep; 179(9):1242-1253. PubMed ID: 31305874
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial.
    Trigo JM; Soliman A; Quilty LC; Fischer B; Rehm J; Selby P; Barnes AJ; Huestis MA; George TP; Streiner DL; Staios G; Le Foll B
    PLoS One; 2018; 13(1):e0190768. PubMed ID: 29385147
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial.
    Gray KM; Baker NL; McClure EA; Tomko RL; Squeglia LM; Saladin ME; Carpenter MJ
    JAMA Pediatr; 2019 Dec; 173(12):1146-1153. PubMed ID: 31609433
    [TBL] [Abstract][Full Text] [Related]  

  • 65. N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease: Rationale for further research.
    Morley KC; Baillie A; Van Den Brink W; Chitty KE; Brady K; Back SE; Seth D; Sutherland G; Leggio L; Haber PS
    Expert Opin Investig Drugs; 2018 Aug; 27(8):667-675. PubMed ID: 30019966
    [TBL] [Abstract][Full Text] [Related]  

  • 66. N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis.
    Fernandes BS; Dean OM; Dodd S; Malhi GS; Berk M
    J Clin Psychiatry; 2016 Apr; 77(4):e457-66. PubMed ID: 27137430
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of Cannabis Use Disorder: Current Science and Future Outlook.
    Sherman BJ; McRae-Clark AL
    Pharmacotherapy; 2016 May; 36(5):511-35. PubMed ID: 27027272
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vilazodone for cannabis dependence: A randomized, controlled pilot trial.
    McRae-Clark AL; Baker NL; Gray KM; Killeen T; Hartwell KJ; Simonian SJ
    Am J Addict; 2016 Jan; 25(1):69-75. PubMed ID: 26685701
    [TBL] [Abstract][Full Text] [Related]  

  • 69. N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Sinclair B; Reid D; Baker AL; Manning V; Pas NT; Thomas T; Bathish R; Raftery DK; Wrobel A; Saunders L; Arunogiri S; Cordaro F; Hill H; Hall S; Clare PJ; Mohebbi M; Berk M
    EClinicalMedicine; 2021 Aug; 38():101005. PubMed ID: 34308314
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial.
    Freeman TP; Hindocha C; Baio G; Shaban NDC; Thomas EM; Astbury D; Freeman AM; Lees R; Craft S; Morrison PD; Bloomfield MAP; O'Ryan D; Kinghorn J; Morgan CJA; Mofeez A; Curran HV
    Lancet Psychiatry; 2020 Oct; 7(10):865-874. PubMed ID: 32735782
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine.
    Tomko RL; Gilmore AK; Gray KM
    Addict Behav; 2018 Oct; 85():26-30. PubMed ID: 29803870
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adolescent Substance Use Disorders.
    Simon KM; Levy SJ; Bukstein OG
    NEJM Evid; 2022 Jun; 1(6):EVIDra2200051. PubMed ID: 38319247
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorder.
    Sahlem GL; Kim B; Baker NL; Wong BL; Caruso MA; Campbell LA; Kaloani I; Sherman BJ; Ford TJ; Musleh AH; Kim JP; Williams NR; Manett AJ; Kratter IH; Short EB; Killeen TK; George MS; McRae-Clark AL
    Drug Alcohol Depend; 2024 Jan; 254():111035. PubMed ID: 38043228
    [TBL] [Abstract][Full Text] [Related]  

  • 74. N-acetylcysteine Pharmacology and Applications in Rare Diseases-Repurposing an Old Antioxidant.
    Sahasrabudhe SA; Terluk MR; Kartha RV
    Antioxidants (Basel); 2023 Jun; 12(7):. PubMed ID: 37507857
    [TBL] [Abstract][Full Text] [Related]  

  • 75. N-acetylcysteine for smoking cessation among dual users of tobacco and cannabis: Protocol and rationale for a randomized controlled trial.
    Herbst ED; Pennington DL; Borsari B; Manuel J; Yalch M; Alcid E; Martinez Rivas M; Delacruz J; Rossi N; Garcia B; Wong N; Batki SL
    Contemp Clin Trials; 2023 Aug; 131():107250. PubMed ID: 37271412
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Who responds to a multi-component treatment for cannabis use disorder? Using multivariable and machine learning models to classify treatment responders and non-responders.
    Tomko RL; Wolf BJ; McClure EA; Carpenter MJ; Magruder KM; Squeglia LM; Gray KM
    Addiction; 2023 Oct; 118(10):1965-1974. PubMed ID: 37132085
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intrusive thinking: Circuit and synaptic mechanisms of a transdiagnostic psychiatric symptom.
    Kalivas PW; Gourley SL; Paulus MP
    Neurosci Biobehav Rev; 2023 Jul; 150():105196. PubMed ID: 37094741
    [TBL] [Abstract][Full Text] [Related]  

  • 78. THC and CBD: Villain versus Hero? Insights into Adolescent Exposure.
    Pintori N; Caria F; De Luca MA; Miliano C
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982327
    [TBL] [Abstract][Full Text] [Related]  

  • 79. N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial.
    Kirkland AE; Browning BD; Green R; Liu H; Maralit AM; Ferguson PL; Meyerhoff DJ; Prisciandaro JJ; Miranda R; Brady KT; Tomko RL; Gray KM; Squeglia LM
    Neuropsychopharmacology; 2023 Jul; 48(8):1184-1193. PubMed ID: 36878996
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of Adolescent Cannabis Use Disorders.
    Adams ZW; Marriott BR; Hulvershorn LA; Hinckley J
    Child Adolesc Psychiatr Clin N Am; 2023 Jan; 32(1):141-155. PubMed ID: 36410901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.